C.Q. Pharmaceutical Holding Co., Ltd. engages in the wholesale and retail of medicines and medical devices. The company is involved in the pharmaceutical commer...
A-share pharmaceutical commercial stocks continue to decline, with Shuyu Pingmin dropping over 18%. HRPC, DAJIAWEIKANG, INT'L GROUP, and Hezong Medicine Easy-To-Buy Pharmaceutical all fell more than 5%, while Huaren Health, CQP, and Kaikai Industry also followed suit
CQP: As of the end of October, a total of RMB 80.9988 million has been spent to repurchase shares
General Technology CQP signs strategic cooperation agreement with Johnson & Johnson Innovation Pharmaceuticals
CQP: In the third quarter, the net profit attributable to the parent company was 102 million yuan, an increase of 87.94% year-on-year
CQP: It is expected that the net profit for the first three quarters will increase by 22.51%-36.88% year-on-year
CQP: The clinical trial for hydrochloride prasugrel tablets has been approved